JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pediani, J. D.
Right arrow Articles by McGrath, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pediani, J. D.
Right arrow Articles by McGrath, J. C.

Vol. 293, Issue 3, 887-895, June 2000

Single-Cell Recombinant Pharmacology: Bovine alpha 1a-Adrenoceptors in Rat-1 Fibroblasts Release Intracellular Ca2+, Display Subtype-Characteristic Agonism and Antagonism, and Exhibit an Antagonist-Reversible Inverse Concentration-Response Phase1

John Daniel Pediani, Janet Fraser MacKenzie, Robert Paul Heeley2, Craig James Daly and John Christie McGrath

Autonomic Physiology Unit, Division of Neuroscience and Biomedical Systems, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, United Kingdom

Phe-activated Ca2+ signals recorded from single rat-1 fibroblasts stably expressing the bovine alpha 1a-adrenoceptor (AR) were characterized and used to analyze functional agonist-antagonist interactions. The response to Phe was initiated by the mobilization of stored Ca2+ and subsequently sustained by receptor-regulated Ca2+ influx. The selective alpha 1A-AR agonist (R)-A-61603 was 141-fold more potent as an agonist than Phe. This potency ratio was consistent with the pharmacology of the native alpha 1A-ARs. Functional responses evoked by concentrations of Phe of more than 0.3 µM displayed fade, which could be explained by agonist-dependent depletion of Ca2+ stores. The antagonists tested did not conform to the predictions of the Schild equation for competitive antagonism as expected from the nonequilibrium nature of the response. The antagonist potency series WB4101 >=  prazosin BMY7378, however, was consistent with alpha 1A-ARs. Antagonism exhibited by WB4101 and prazosin was compatible with a model in which antagonists dissociate so slowly from the receptor that this is a major factor in their inhibition of the transient agonist-mediated response, leading to the appearance of insurmountable antagonism. A consequence of this phenomenon was that an inverse concentration-response relationship at high agonist concentrations was abolished by low concentrations of antagonists. Overall, the results indicate that quantitative pharmacology can be studied successfully in single cells even though equilibrium could not be achieved in the agonist-antagonist-response relationship in this particular cell phenotype. The study also showed a form of fade that could be readily explained.


1 This work was supported by Medical Research Council, European Commission, Pfizer, and the British Heart Foundation.

2 Present address: Cruachem Ltd., Acre Rd., West of Scotland Science Park, Scotland.


0022-3565/00/2933-0887$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Exp PhysiolHome page
J. C McGrath, C. Deighan, A. M Briones, M. M. Shafaroudi, M. McBride, J. Adler, S. M Arribas, E. Vila, and C. J Daly
New aspects of vascular remodelling: the involvement of all vascular cell types
Exp Physiol, July 1, 2005; 90(4): 469 - 475.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. D. Pediani, J. F. Colston, D. Caldwell, G. Milligan, C. J. Daly, and J. C. McGrath
{beta}-Arrestin-Dependent Spontaneous {alpha}1a-Adrenoceptor Endocytosis Causes Intracellular Transportation of {alpha}-Blockers via Recycling Compartments
Mol. Pharmacol., April 1, 2005; 67(4): 992 - 1004.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.